Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Marsh

Showing results (851-860 of 897) with videos related to

Pageof 90
Sort By:
European Journal of Pharmacology|August 15, 2002
The role of melanocortins in body weight regulation: opportunities for the treatment of obesityDouglas J MacNeil, Andrew D Howard, Xiaoming Guan, et al.
Obesity (Silver Spring, Md.)|May 15, 2013
Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight and modulates gut peptide release--potential insight into mechanism of actionJinqi Liu, Judith N Gorski, Stephen J Gold, et al.
Cancer Research|October 20, 2004
Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotypeCarola J Haven, Viive M Howell, Paul H C Eilers, et al.
Diabetes|July 16, 2009
Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in miceAlessandro Pocai, Paul E Carrington, Jennifer R Adams, et al.
Gastroenterology|January 3, 2021
Colonic Epithelial-Derived Selenoprotein P Is the Source for Antioxidant-Mediated Protection in Colitis-Associated CancerSarah P Short, Jennifer M Pilat, Caitlyn W Barrett, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of MK-5046, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of ObesityIyassu K Sebhat, Christopher Franklin, Michael M-C Lo, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 2, 2010
Antiobesity effect of MK-5046, a novel bombesin receptor subtype-3 agonistXiao-Ming Guan, Joseph M Metzger, Liming Yang, et al.
Nature Genetics|September 6, 2000
Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body massA S Chen, D J Marsh, M E Trumbauer, et al.
Obstetrics and Gynecology|April 10, 2018
Prescription and Other Medication Use in PregnancyDavid M Haas, Derek J Marsh, Danny T Dang, et al.
JAMA|November 20, 1996
The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysisC Eng, D Clayton, I Schuffenecker, et al.
Pageof 90

Showing results (851-860 of 897) with videos related to

Sort By:
Pageof 90
European Journal of Pharmacology|August 15, 2002
The role of melanocortins in body weight regulation: opportunities for the treatment of obesityDouglas J MacNeil, Andrew D Howard, Xiaoming Guan, et al.
Obesity (Silver Spring, Md.)|May 15, 2013
Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight and modulates gut peptide release--potential insight into mechanism of actionJinqi Liu, Judith N Gorski, Stephen J Gold, et al.
Cancer Research|October 20, 2004
Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotypeCarola J Haven, Viive M Howell, Paul H C Eilers, et al.
Diabetes|July 16, 2009
Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in miceAlessandro Pocai, Paul E Carrington, Jennifer R Adams, et al.
Gastroenterology|January 3, 2021
Colonic Epithelial-Derived Selenoprotein P Is the Source for Antioxidant-Mediated Protection in Colitis-Associated CancerSarah P Short, Jennifer M Pilat, Caitlyn W Barrett, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of MK-5046, a Potent, Selective Bombesin Receptor Subtype-3 Agonist for the Treatment of ObesityIyassu K Sebhat, Christopher Franklin, Michael M-C Lo, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 2, 2010
Antiobesity effect of MK-5046, a novel bombesin receptor subtype-3 agonistXiao-Ming Guan, Joseph M Metzger, Liming Yang, et al.
Nature Genetics|September 6, 2000
Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body massA S Chen, D J Marsh, M E Trumbauer, et al.
Obstetrics and Gynecology|April 10, 2018
Prescription and Other Medication Use in PregnancyDavid M Haas, Derek J Marsh, Danny T Dang, et al.
JAMA|November 20, 1996
The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysisC Eng, D Clayton, I Schuffenecker, et al.
Pageof 90